EUVIMEDEUVIMED entdecken
Crossref

PLK1 Downregulation Attenuates ET-1-Induced Cardiomyocyte Hypertrophy by Suppressing the ERK1/2 Pathway

Jie Ding, Anqi Yang, Liping Zhou, Fulei Zhang, Huixing Zhou, Yuemei Zhang, Yan Wang, Yi Liu, Dandan Liang, Yuanyuan Liu, Yahan Wu iD

Journal of Cardiovascular Translational Research · 2025

DOI: 10.1007/s12265-025-10604-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Translational Research, 2025. Verfasst von Jie Ding und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Cardiomegaly, Endothelin-1, Protein Serine-Threonine Kinases. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Shanghai Municipal Education Commission, China Postdoctoral Science Foundation, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiomyocyte hypertrophy is a key remodeling response to cardiac stress and an independent risk factor for heart failure. However, the molecular mechanism of cardiomyocyte hypertrophy is not yet fully understood. We here found Polo-like kinase 1 (PLK1) was crucial in regulating endothelin-1 (ET-1)-induced cardiomyocyte hypertrophy. Notably, PLK1 expression was significantly elevated in ET-1-induced hypertrophic cardiomyocytes and pressure overload-induced hypertrophic cardiac tissue. Knocking down Plk1 reduced the cell size of hypertrophic cardiomyocytes and suppressed the expression of hypertrophic markers, including ANP, BNP and β-MHC. The PLK1 inhibitor BI2536 had similar effects on hypertrophic cardiomyocytes. Mechanistically, the ERK1/2 pathway was identified as the key downstream pathway mediating the effects of PLK1 on ET-1-induced cardiomyocyte hypertrophy. Finally, the deficiency of PLK1 attenuated the hypertrophy of hiPSC-CMs. In summary, our study revealed that PLK1 regulates ET-1-induced cardiomyocyte hypertrophy through the ERK1/2 pathway, providing insights into the pathogenesis and potential therapies for pathological cardiac hypertrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacCardiomegalyEndothelin-1Protein Serine-Threonine KinasesProto-Oncogene ProteinsCell Cycle ProteinsMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase 1MAP Kinase Signaling SystemAnimalsPolo-Like Kinase 1Disease Models, AnimalDown-RegulationMaleCells, CulturedMice, Inbred C57BLVentricular RemodelingRats, Sprague-DawleyHumans

Stichwörter der Autor:innen

Cardiomyocyte HypertrophyERK1/2Endothelin-1PLK1hiPSC-CMs

Substanzen

Polo-Like Kinase 1Endothelin-1Protein Serine-Threonine KinasesProto-Oncogene ProteinsCell Cycle ProteinsMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase 1

Autor:innen und Institutionen

  • Department of Cardiology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
  • Jinzhou Medical University, Jinzhou, 121000, China.
  • Jinzhou Medical University, Jinzhou, 121000, China. liuyuanyuan201310@163.com.
  • Department of Cardiology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China. wuyahan_qirmai@163.com.

ORCID-Profile: Yahan Wu

Förderung

  • Shanghai Municipal Education Commission
  • China Postdoctoral Science Foundation
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Pudong New Area Health Commission

Zitieren

APA

Ding, J., Yang, A., Zhou, L., Zhang, F., Zhou, H., Zhang, Y., Wang, Y., Liu, Y., Liang, D., Liu, Y., & Wu, Y. (2025). PLK1 Downregulation Attenuates ET-1-Induced Cardiomyocyte Hypertrophy by Suppressing the ERK1/2 Pathway. Journal of Cardiovascular Translational Research. https://doi.org/10.1007/s12265-025-10604-3

Vancouver

Ding J, Yang A, Zhou L, Zhang F, Zhou H, Zhang Y, et al. PLK1 Downregulation Attenuates ET-1-Induced Cardiomyocyte Hypertrophy by Suppressing the ERK1/2 Pathway. Journal of Cardiovascular Translational Research. 2025. doi:10.1007/s12265-025-10604-3

BibTeX
@article{Ding2025,
  author = {Ding, Jie and Yang, Anqi and Zhou, Liping and Zhang, Fulei and Zhou, Huixing and Zhang, Yuemei and Wang, Yan and Liu, Yi and Liang, Dandan and Liu, Yuanyuan and Wu, Yahan},
  title = {PLK1 Downregulation Attenuates ET-1-Induced Cardiomyocyte Hypertrophy by Suppressing the ERK1/2 Pathway},
  journal = {Journal of Cardiovascular Translational Research},
  year = {2025},
  doi = {10.1007/s12265-025-10604-3}
}
Kostenlos starten →